Combination of Anti-VEGF and Laser Photocoagulation for Diabetic Macular Edema: A Review
Diabetic macular edema (DME) is the most common cause of vision loss in diabetic patients. Thirty years ago, the Early Treatment Diabetic Retinopathy Study (ETDRS) demonstrated that focal/grid laser photocoagulation reduces moderate vision loss from DME by 50% or more; thus, macular photocoagulation...
Saved in:
Main Authors: | Laura N. Distefano, Jose Garcia-Arumi, Vicente Martinez-Castillo, Anna Boixadera |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2017/2407037 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combination of Navigated Macular Laser Photocoagulation and Anti-VEGF Therapy: Precise Treatment for Macular Edema under Dry Retinal Conditions
by: Ernest V. Boiko, et al.
Published: (2017-01-01) -
Coats’ Disease-Related Macular Edema Treated with Combined Aflibercept and Laser Photocoagulation
by: Wen-Shi Shieh, et al.
Published: (2017-01-01) -
Evaluation of Navigated Laser Photocoagulation (Navilas 577+) for the Treatment of Refractory Diabetic Macular Edema
by: Fusae Kato, et al.
Published: (2018-01-01) -
Application of deep learning algorithm for judicious use of anti-VEGF in diabetic macular edema
by: Anwesa Mondal, et al.
Published: (2025-02-01) -
Switch to Aflibercept in Diabetic Macular Edema Patients Unresponsive to Previous Anti-VEGF Therapy
by: Filipe Mira, et al.
Published: (2017-01-01)